Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making.
Investigators conducted a study to determine if patients experienced delays in treatment for early-stage breast cancer as a result of the COVID-19 pandemic.
A case study with a literature review demonstrates potential antiviral effect of TKI therapy in patients with cancer and COVID-19.
Fully vaccinated individuals can visit with other fully vaccinated people, or unvaccinated people from a single household who are at low risk for severe COVID-19 disease, indoors without wearing masks or physical distancing.
A team of researchers conducted a study to assess the impact of the COVID-19 pandemic on the initiation of clinical trials in oncology.
The EUA was based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.
Patients who have undergone either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) are at high risk for mortality in the event of a COVID-19 diagnosis.
This fact sheet reviews the current guidelines for coronavirus disease 2019 (COVID-19) vaccination in patients with cancer.
Researchers at Memorial Sloan Kettering Cancer Center investigated the incidence of neurologic sequelae of COVID-19 in patients with cancer.
In an online survey, 17.2% of patients with genitourinary cancers reported they delayed or avoided seeking medical care because of the COVID-19 pandemic.
